We found 4 mohs skin cancer surgeons who accept Humana Simplicity HMO Open Access Silver 04/100 near Chicago, IL.

Showing 1-4 of 4
Selecting one of the sort options will cause this page to reload and list providers by the selected sort order.
Dr. Aleksandar Ljubisav Krunic, PhD, MD
Specializes in MOHS-Micrographic Surgery
820 South Damen Avenue
Chicago, IL

Dr. Aleksandar Krunic practices MOHS-micrographic surgery. On average, patients gave him a rating of 2.5 stars out of 5. His areas of expertise include the following: rosacea, acne, and spider veins. Dr. Krunic is an in-network provider for Blue Cross/Blue Shield, Coventry, and TRICARE, in addition to other insurance carriers. He attended the University of Belgrade School of Medicine and subsequently trained at the University of Chicago Medical Center for residency. Dr. Krunic has received professional recognition including the following: Chicago Super Doctors. Dr. Krunic (or staff) is conversant in Croatian, Serbian, and Italian. He is professionally affiliated with Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, and Swedish Covenant Hospital. He is accepting new patients.

Read more

Clinical interests: Cryosurgery, Eczema, Atopic Dermatitis, Sclerotherapy, Contact Dermatitis, Erythroderma, Chemical ... (Read more)

Dr. Vassilios A Dimitropoulos, MD
Specializes in MOHS-Micrographic Surgery
1801 W. Taylor Street; Outpatient Care Center, Suite 3e
Chicago, IL

Dr. Vassilios Dimitropoulos works as a mohs skin cancer surgeon in Darien, IL, Skokie, IL, and Chicago, IL. Areas of expertise for Dr. Dimitropoulos include warts, chemical peels, and moles. Dr. Dimitropoulos's hospital/clinic affiliations include Adventist Medical Center Bolingbrook, the University of Illinois Hospital & Health Sciences System (UI Health), and Adventist Medical Center Hinsdale. He accepts Blue Cross/Blue Shield, Coventry, TRICARE, and more. His education and training includes medical school at Rush Medical College and residency at a hospital affiliated with the University of Michigan. Dr. Dimitropoulos (or staff) speaks the following languages: Spanish, Greek, and Russian.

Read more

Clinical interests: Warts, Eczema, Chemical Peels, Skin Cancer, Cosmetic Skin Treatment, Mohs Surgery, Skin Cancer ... (Read more)

Specializes in Pediatric Dermatology, MOHS-Micrographic Surgery
1740 W Taylor Street
Chicago, IL

Dr. Paul Storrs specializes in pediatric dermatology and MOHS-micrographic surgery. He is a graduate of the University of Illinois College of Medicine at Chicago. He takes several insurance carriers, including Humana HMO, Humana Bronze, and Humana Catastrophic.

Read more

Specializes in MOHS-Micrographic Surgery
1740 West Taylor Street
Chicago, IL

Dr. Eiman Nasseri is a mohs skin cancer surgeon in Chicago, IL. He honors Humana HMO, Humana Bronze, Humana Catastrophic, and more.

Read more

Conditions / Treatments


New Patients


Medicare Patient Age

Medicare Patient Conditions

Medicare Patient Ethnicity

Medicare Patient Gender

Medicare Patient Insurance Eligibility

Additional Information


Foreign Language


Online Communication

Patient Demographic

Practice Affiliation




Medical School


Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.
Selecting a checkbox option will refresh the page.